Why Canadian public healthcare fails Lyme patients and why they seek treatment elsewhere
Promoting Canadian research and researchers.
Insert HTML here
Promoting Canadian research and researchers.
Published November 2022 Background: Lyme disease (LD) is a complex tick-borne pathology caused by Borrelia burgdorferi sensu lato bacteria. Currently, there are limited data regarding the health outcomes of people infected during pregnancy, the potential for perinatal transmission to their fetus, and the long-term effects on these children. Therefore, the primary objective of this survey study was to…
Abstract Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in USA and Europe. Despite the standard 2-4 weeks antibiotic treatment, approximately 10%-20% of patients will develop post-treatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not…
July 26, 2022 Abstract Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in USA and Europe. Despite the standard 2-4 weeks antibiotic treatment, approximately 10%-20% of patients will develop post-treatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms…
By Pamela Weintraub “Many physicians who treat tick-borne diseases now combine conventional medicine with gentler integrative strategies — and more long-term patients are getting well. In the summer of 1997, Jennifer Crystal discovered a red, splotchy rash on her arm. A 19-year-old counselor at a camp in Maine at the time, Crystal had grown up…
Sadly this lack of help for adequate Lyme disease treatment is a Canada-wide problem due in large part to the very poor information given to physicians and other medical professionals by a private self-proclaimed expert group called the Association of Medical Microbiology and Infectious Diseases Canada. Provincial and federal governments have ceded control over the…
Sarah explores the latest advances in Lyme disease treatment with Dr. Kim Lewis, a researcher, author, University Distinguished Professor and director of Antimicrobial Discovery Center at Northeastern University in Boston. He specializes in molecular science and is currently researching persister cells that lead to tolerance to antibiotics, uncultured bacteria of the environment and the microbiome…
October 2021 Summary Lyme disease is on the rise. Caused by a spirochete Borreliella burgdorferi, it affects an estimated 500,000 people in the United States alone. The antibiotics currently used to treat Lyme disease are broad spectrum, damage the microbiome, and select for resistance in non-target bacteria. We therefore sought to identify a compound acting selectively…
June 8th 2021 “The (symptoms) affected every system in my body, pretty much,” said Lugar, who was experiencing vision, hearing, and digestive issues, as well as extreme fatigue and light and sound sensitivity. “At my worst, I was in bed, in a darkened room. At my best, I could function at about 60 per cent.”…
Nov. 20, 2020 KENDAL, ONT. — Kevin Matthews was a healthy 58 year old trying to ease into a slower lifestyle, but things took a turn on a trip in 2017. That was the year he was hunting near Kingston, Ont. and was bitten by a tick. He recalls extracting the arthropod from his stomach,…
“In this episode, Sarah hears from Alexis Chesney, a naturopathic physician in Vermont who specializes in Lyme disease and other tick-borne illnesses. She is also author of the book “Preventing Lyme and Other Tick-Borne Diseases”. ” “She points to the different roles practitioners have in a patient’s care, including primary care physicians and specialists such…
Abstract Objective: Chronic Lyme disease has been a poorly defined term and often dismissed as a fictitious entity. In this paper, the International Lyme and Associated Diseases Society (ILADS) provides its evidence-based definition of chronic Lyme disease. Definition: ILADS defines chronic Lyme disease (CLD) as a multisystem illness with a wide range of symptoms and/or…
This article is a preprint and has not been certified by peer review – Posted Nov 15th, 2019 ABSTRACT Lyme disease caused by the Borrelia burgdorferi (Bb or B. burgdorferi) is a most common vector-borne, multi-systemic disease in USA. Although, most Lyme disease patients can be cured with a course of antibiotic treatment, a significant percent of…
[CanLyme Note: Patient representatives and their experts have been directly involved in the set up for this project in Manitoba so we are very hopeful this can evolve into a model of care Canada-wide that is so desperately needed.] November 11th, 2019 Program will connect primary health providers, patients to specialists to help treat tick-borne illnesses…
published June 17th, 2019 A Virginia Tech biochemist has discovered the cellular component that contributes to Lyme arthritis, a debilitating and extremely painful condition that is the most common late stage symptom of Lyme disease, a press release said. According to the release from Virginia Tech, the biochemist, Brandon Jutras, found that as the Lyme-causing bacteria borrelia burgdorferi multiplies, it…